AbbVie Inc. buy melinda
Start price
05.06.22
/
10%
€137.98
Target price
05.06.23
€155.00
Performance (%)
-7.09%
End price
06.06.23
€128.20
Summary
This prediction ended on 06.06.23 with a price of €128.20. With a performance of -7.09%, the BUY prediction for AbbVie Inc. by melinda closed slightly in the red. melinda has a follow-up prediction for AbbVie Inc. where he still thinks AbbVie Inc. is a Buy. Dividends of €5.55 are taken into consideration when calculating the performance. melinda has 10% into this predictionAbbVie (ABBV) is a multinational biopharmaceutical company based in North Chicago, Illinois. It was spun off as a separate entity from Abbott Laboratories in 2013 and is primarily focused on the development and commercialization of drugs for the treatment of conditions such as immunology, oncology, and neuroscience. Its key product is Humira, which is used to treat a range of autoimmune diseases, generating a significant portion of the company's revenue. The company also has a pipeline of promising products in various stages of development, making it a reputable player in the pharmaceutical industry.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| AbbVie Inc. | 1.956% | 1.956% | 13.313% |
| iShares Core DAX® | -0.922% | -1.078% | 12.165% |
| iShares Nasdaq 100 | 0.371% | -0.556% | 38.622% |
| iShares Nikkei 225® | 2.224% | -2.825% | 19.015% |
| iShares S&P 500 | -0.026% | -0.788% | 28.485% |
According to melinda what are the pros and cons of AbbVie Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread AbbVie Inc. diskutieren
Buy AbbVie Inc.
Kursziel gesetzt auf 155,0
In the thread Trading AbbVie Inc.
Die von melinda gewählte maximale Laufzeit wurde überschritten
Current prediction by melinda for AbbVie Inc.
AbbVie Inc.
Start price
Target price
Perf. (%)
€126.10
17.06.23
17.06.23
-
17.06.24
17.06.24
23.77%
19:56
19:56
Could be worthwhile Investment >10% per year
Stopped prediction by melinda for AbbVie Inc.
AbbVie Inc.
Start price
Target price
Perf. (%)
€73.20
01.11.19
01.11.19
€98.00
04.11.21
04.11.21
37.84%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€89.22
15.06.18
15.06.18
€189.42
17.12.18
17.12.18
-11.51%
17.12.18
17.12.18
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€85.54
28.03.18
28.03.18
€97.87
23.05.18
23.05.18
11.86%
23.05.18
23.05.18
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€107.50
12.03.18
12.03.18
€113.52
28.03.18
28.03.18
-20.52%
28.03.18
28.03.18
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€76.18
10.09.17
10.09.17
€81.18
28.09.17
28.09.17
6.74%
28.09.17
28.09.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€84.46
10.09.17
10.09.17
€90.00
28.09.17
28.09.17
6.74%
28.09.17
28.09.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€64.95
10.08.17
10.08.17
€66.75
30.08.17
30.08.17
2.81%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€72.01
10.08.17
10.08.17
€74.00
30.08.17
30.08.17
2.81%
30.08.17
30.08.17
Could be worthwhile Investment >10% per year
AbbVie Inc.
Start price
Target price
Perf. (%)
€56.36
07.05.16
07.05.16
€55.92
12.05.16
12.05.16
0.12%
12.05.16
12.05.16
Could be worthwhile Investment >10% per year